期刊文献+

前列腺素E1在心血管疾病中的应用及不良反应护理干预 被引量:6

Clinical application of prostaglandin E1 in cardiovascular diseases and nursing intervention for its adverse reactions
下载PDF
导出
摘要 查阅近5年内国内外相关文献,对前列腺素E1的药理作用、临床应用及不良反应的护理干预等进行归纳总结。前列腺素E1具有改善血流动力学、抑制血小板聚集、保护血管内皮细胞的作用;治疗冠心病、心力衰竭、风湿性心脏病和先天性心脏病等疗效卓著;常见不良反应有静脉炎、血压下降、胃肠道反应等,有效的护理干预可防治不良反应的发生。 The pertinent literatures reported in the recent 5 years were referred to introduce the pharmacological actions and the clinical application of prostaglandin E 1 (PGE 1 ) in cardiovascular diseases and nursing intervention for its adverse reactions. PGE1 can ameliorate hemodynamics, decrease platelet conglomeration and protect vascular endothelial cell. It showed a significant therapeutic effect on cardiovascular diseases such as coronary heart disease, congestive heart failure, rheumatic heart disease and congenital heart disease. The common side effects include phlebitis, hypotension, gastrointestinal tract reaction, which can be prevented and cured by effective nursing intervention.
出处 《中国药物应用与监测》 CAS 2010年第1期58-60,共3页 Chinese Journal of Drug Application and Monitoring
关键词 前列腺素E1 心血管疾病 不良反应 护理 Prostaglandin El Cardiovascular disease Adverse reaction Nursing
  • 相关文献

参考文献15

  • 1Heider P, Wildgruber M, Wolf O, et al. Improvement of microcireulation after percutaneous transluminal angioplasty in the lower limb with prostaglandin E1 [J]. Prostaglandins Other Lipid Mediat, 2009, 88(1-2): 23-30.
  • 2Wu CC, Wu CI, Wang WY, et al. Low concentrations of resveratrol potentiate the antiplatelet effect of prostaglandins[J].Planta Med, 2007, 73(5): 439-443.
  • 3Gensch C, Clever Y, Werner C, et al. Regulation of endothelial progenitor cells by prostaglandin E1 via inhibition of apoptosis[J]. J Mol Cell Cardiol, 2007, 42(3): 670-677.
  • 4Mehrabi MR, Serbecic N, Tamaddon F, et al. Clinical and experimental evidence of prostaglandin E 1-induced angiogenesis in the myocardium of patients with ischemic heart disease[J]. Cardiovasc Res, 2002, 56(2): 214-224.
  • 5李悦,王海英,王丽馥.注射用前列腺素E_1治疗不稳定型心绞痛的疗效观察[J].临床和实验医学杂志,2009,8(1):100-101. 被引量:3
  • 6Mehrabi MR, Serbecic N, Tamaddon F, et al. Clinical benefit of prostaglandin El-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium[J]. Biomed Pharmacother, 2003, 57(3-4): 173-178.
  • 7郭舜奇,陈平,蔡志雄,朱稚丹,林浩.直接经皮冠状动脉成形术联合脂微球载体前列腺素E1治疗老年急性心肌梗死[J].中国现代药物应用,2008,2(22):34-36. 被引量:2
  • 8von Scheidt W, Costard-Jaeckle A, Stempfle M, et al. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study[J]. J Heart Lung Transplant, 2006, 25(9): 1070-1076.
  • 9卢青,周晓芳,钟萍,张焰,张新星,王文艳.前列腺素E_1治疗老年慢性心力衰竭的临床观察[J].四川医学,2007,28(12):1344-1345. 被引量:2
  • 10李志平,范士志,蒋耀光,王如文,陈建明,牛会军,何勇,郭伟,沈诚.风心病合并肺动脉高压体外循环后前列腺素E_1抵抗现象的研究[J].第三军医大学学报,2007,29(9):792-795. 被引量:3

二级参考文献53

共引文献33

同被引文献55

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部